Melanotan II comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-04-16. Numbers and descriptions here follow the published literature rather than marketing material.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Belongs to the melanocortin agonist family |
| Key substitutions | Nle4 and D-Phe7 | Improve resistance to enzymatic degradation |
| Molecular formula | C50H69N15O9 | Approximately 1024 g/mol |
| Regulatory status | Not approved as a medicine | Distributed as a research chemical |
| Common synonyms | Melanotan II, MT-II, MT-2 | Spelling varies across sources |
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
1993/584) National Blood Authority (Establishment and Constitution) Order 1993 (S.I. 1993/585) National Blood Authority Regulations 1993 (S.I. 1993/586) Central Blood Laboratories Authority (Revocation) Order 1993 (S.I. 1993/587) Nurses, Midwives and Health Visitors Act 1992 (Commencement No. 1) Order 1993 (S.I. 1993/588) Registration of Births, Deaths and Marriages (Fees) (Amendment) (No. 2) Order 1993 (S.I. 1993/589) United Kingdom Central Council for Nursing, Midwifery and Health Visiting (Term of Office of Members) Order 1993 (S.I. 1993/590) Recovery of Maintenance (United States of America) Order 1993 (S.I. 1993/591) Social Security (Northern Ireland) Order 1993 (S.I. 1993/592) Reciprocal Enforcement of Maintenance Orders (Hague Convention Countries) Order 1993 (S.I. 1993/593) Reciprocal Enforcement of Maintenance Orders (Republic of Ireland) Order 1993 (S.I. 1993/594) European Communities (Designation) Order 1993 (S.I. 1993/595) Veterinary Surgeons Qualifications (EEC Recognition) (Amendment) Order 1993 (S.I. 1993/596) Home Guard (Amendment) Order 1993 (S.I. 1993/597) Naval, Military and Air Forces etc. (Disablement and Death) Service Pensions Amendment Order 1993 (S.I. 1993/598) Continental Shelf (Designation of Areas) Order 1993 (S.I. 1993/599)
The method opened the door to the development of large-scale technological applications of quantum dots in a wide range of areas. The Nobel Prize in Chemistry 2023 was awarded to Moungi Bawendi, Louis E. Brus and Alexey Ekimov "for the discovery and synthesis of quantum dots."
In 2011, Sá Fernandes said that he had a solid accusation, but did not want to turn Dias into a "scapegoat," and in case there was any doubt, he would not ask for his conviction."We are sure that the defendant consummated the crime [of kidnapping] (...) doesn't have the slight sign of regret. Acts with total indifference (...) It was proven that the defendant kidnapped Rui Pedro, taking him to Lustosa against the minor's parent's will. (...) I evaluated the evidence and reached the conclusion that the defendant is the author of the facts judged here. I ask for justice and humanity for the case's resolution. In the end of this process there is sorrow and anguish for not finding out what happened to Pedro. The Public Prosecution asks for justice and waits for it to be done" - Public Prosecution, 2012When Dias' arrest was definitely announced, Manuel Mendonça said that the now convicted had multiple opportunities to tell what he did to Mendonça, even by anonymous letter and highlighted that he did not want his conviction. After being freed, Dias said in 2018 that he was a victim of "a great injustice" and blamed Mendonça's family for his jail time.
Sources: en.wikipedia.org
=== Society and culture === The use of sovereign power, codes of conduct, religious and cultural practices and other dynamic processes in a society can be described as a part of an evolved homeostatic system of regularizing life and maintaining an overall equilibrium that protects the security of the whole from internal and external imbalances or dangers. Healthy civic cultures can be said to have achieved an optimal homeostatic balance between multiple contradictory concerns such as in the tension between respect for individual rights and concern for the public good, or that between governmental effectiveness and responsiveness to the interests of citizens.
=== Ostwald ripening === Ostwald ripening is a process in which large particles grow at the expense of the smaller particles as a result of dissolution of small particles and deposition of the dissolved molecules on the surfaces of the larger particles. It occurs because smaller particles have a higher surface energy than larger particles. This process is typically undesirable in nanoparticle synthesis as it negatively impacts the functionality of nanoparticles.
Antiviral proteins are proteins that are induced by human or animal cells to interfere with viral replication. These proteins are isolated to inhibit the virus from replicating in a host's cells and stop it from spreading to other cells. The Pokeweed antiviral protein and the Zinc-Finger antiviral protein are two major antiviral proteins that have undergone several tests for viruses, including HIV and influenza.
Sources: en.wikipedia.org
In 1961, Vsevolod Klechkovsky derived the first part of the Madelung rule (that orbitals fill in order of increasing n + ℓ) from the Thomas–Fermi model; the complete rule was derived from a similar potential in 1971 by Yury N. Demkov and Valentin N. Ostrovsky.
Kwäday Dän Ts'ìnchi ("Long ago person found" in the Southern Tutchone language of the Champagne and Aishihik First Nations), was found in August 1999 by three First Nations hunters at the edge of a glacier in Tatshenshini-Alsek Provincial Park, British Columbia, Canada. According to the Kwäday Dän Ts'ìnchi Project, the remains are the oldest well preserved mummy discovered in North America. (The Spirit Cave mummy although not well preserved, is much older.) Initial radiocarbon tests date the mummy to around 550 years-old.
In November 2019, he imposed a moratorium on approval of new hydraulic fracturing and steam-injected oil drilling in the state until the permits for those projects could be reviewed by an independent panel of scientists. State agencies resumed issuing new hydraulic fracturing permits in April 2020. In 2021, the Center for Biological Diversity sued the Newsom administration over the continued sale of oil and gas leases, and Consumer Watchdog called for the end of their sale. In April 2021, Newsom committed to ending the sale of gas leases by 2024 and ending oil extraction by 2045. In October 2021, he proposed a 3,200-foot (980 m) buffer between new fossil fuel extraction sites and densely populated areas. In 2022, gas prices in California exceeded $6 per gallon. Newsom attributed this to corporate greed and price gouging by oil companies. He proposed a windfall profits tax and penalty for oil companies in September 2022. On March 28, 2023, Newsom signed a law that authorizes the California Energy Commission to set "a profit threshold above which companies would be assessed a financial penalty", requires petroleum companies to report additional profit data to state regulators, and creates a new oversight division of the California Energy Commission to investigate price gouging in the gasoline industry. In June 2025, Newsom signed California Assembly Bill 130 (2025) into law. In October 2025, Newsom vetoed Senate Bill 682 which sought to limit forever chemicals and Assembly Bill 93 which sought to require data centers to report their water use.
Sources: en.wikipedia.org
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.
No regulatory agency has approved it for any indication. It is encountered as a research chemical sold outside pharmaceutical supply chains. Products marketed this way are not subject to the manufacturing and labeling requirements that apply to approved drugs.
Reports describe increased skin pigmentation as well as side effects such as nausea, flushing, and changes to existing moles. Much of the evidence comes from small studies and case reports rather than large trials. The long-term safety profile is therefore uncertain.
Regulatory treatment varies by country. In the United States, the European Union and Australia it is an unapproved drug and its sale is restricted, while some other jurisdictions list it as prescription-only or controlled. The applicable rules depend on the country of import.